Related Experiment Video

Updated: May 6, 2026

Renal Corpuscle
01:20

Renal Corpuscle

6.9K

Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac

Murugavel Ponnusamy1, Fang Liu2, Yu-Hui Zhang3

  • 1Center for Developmental Cardiology, Institute for Translational Medicine, College of Medicine, Qingdao University, China (M.P., L.-Y.Z., C.-Y.L., K.-W.L., Y.-H.D., M.W., L.-L.Q., C.S., S.X., Q.W., Yan-Hui Zhang, P.-F.L., K.W.).

Circulation
|March 6, 2019
PubMed
Abstract

Insights

Cardiomyocyte proliferation regulator (CPR) suppresses heart cell regeneration. Inhibiting CPR promotes cardiomyocyte proliferation and cardiac repair after injury, offering a new therapeutic strategy for heart failure.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Epigenetics

Background:

  • Adult cardiomyocytes lose proliferative capacity, leading to cardiac dysfunction and heart failure.
  • Molecular mechanisms of attenuated cardiomyocyte proliferation are largely unknown.
  • Long noncoding RNAs (lncRNAs) play roles in cardiovascular disease, prompting investigation into their role in cardiomyocyte proliferation and repair.

Purpose of the Study:

  • To investigate the role of lncRNAs in regulating cardiomyocyte proliferation and cardiac repair.
  • To identify and characterize a novel lncRNA, CPR, involved in cardiomyocyte proliferation.

Main Methods:

  • Bioinformatic analysis to identify potential lncRNAs.
  • Generation of CPR knockout and cardiac-specific CPR-overexpressing mice.
  • In vitro studies using isolated cardiomyocytes with CPR silencing or overexpression.
  • Quantitative PCR, Western blot, histology, echocardiography, transcriptome analysis, RNA pull-down, and ChIP assays to elucidate CPR function and mechanism.

Main Results:

  • CPR levels are higher in adult hearts than fetal hearts.
  • CPR silencing increased cardiomyocyte proliferation in postnatal and adult hearts and restored heart function post-myocardial injury.
  • CPR overexpression suppressed neonatal cardiomyocyte proliferation and cardiac regeneration.
  • CPR suppresses cardiomyocyte proliferation by targeting minichromosome maintenance 3 (MCM3) via recruitment of DNMT3A to the MCM3 promoter, reducing its methylation and increasing its expression.

Conclusions:

  • CPR acts as a negative regulator of cardiomyocyte proliferation and cardiac regeneration.
  • lncRNAs are involved in regulating cardiomyocyte proliferation and cardiac repair.
  • CPR presents a potential lncRNA-based therapeutic target for cardiac repair and regeneration.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.2K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968